Showing results (151-160 of 197) with videos related to

Sort By:
Pageof 20
JHEP Reports : Innovation in Hepatology|June 17, 2025
Prediction of long-term HBsAg seroclearance in patients with HBeAg-negative chronic hepatitis BHae Lim Lee, Soon Kyu Lee, Ji Won Han, et al.
The Korean Journal of Internal Medicine|September 9, 2016
Prevalence and risk factors of periodontitis among adults with or without diabetes mellitusMihee Hong, Hee Yeon Kim, Hannah Seok, et al.
Hepatology International|January 26, 2021
Sorafenib for advanced hepatocellular carcinoma provides better prognosis after liver transplantation than without liver transplantationSoon Kyu Lee, Jeong Won Jang, Heechul Nam, et al.
Journal of Korean Medical Science|August 5, 2017
Validation of a Paper and Pencil Test Battery for the Diagnosis of Minimal Hepatic Encephalopathy in KoreaJae Yoon Jeong, Dae Won Jun, Daiseg Bai, et al.
Autophagy|May 14, 2026
The N-degron pathway regulates glucose and insulin homeostasis through the lysosomal degradation of RXRA/RXRα via SQSTM1/p62Eui Jung Jung, Hye Yeon Kim, Tae Hyun Bae, et al.
The Korean Journal of Hepatology|March 19, 2011
A comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinomaHee Yeon Kim, Jin Dong Kim, Si Hyun Bae, et al.
Life Sciences|December 18, 2021
Vitamin C alleviates alcoholic liver injury by suppressing neutrophil infiltration in senescence marker protein 30-knockout mice irrespective of its antioxidant effectsSu-Min Baek, Seoung-Woo Lee, Young-Jin Lee, et al.
Journal of Clinical Medicine|December 29, 2020
A Real-World Comparative Analysis of Lenvatinib and Sorafenib as a Salvage Therapy for Transarterial Treatments in Unresectable HCCJaejun Lee, Pil Soo Sung, Hyun Yang, et al.
Experimental & Molecular Medicine|October 19, 2018
Farnesyl diphosphate synthase is important for the maintenance of glioblastoma stemnessHee Yeon Kim, Dong Keon Kim, Seung-Hyun Bae, et al.
Liver Cancer|August 8, 2024
Analysis of Immune-Related Adverse Events of Atezolizumab and Bevacizumab in Patients with Hepatocellular Carcinoma: A Multicentre Cohort StudyHeechul Nam, Jaejun Lee, Ji Won Han, et al.
Pageof 20